• by bcarlson@marketresearch.com
  • January 26 2016


India and China IVD Markets Defy Economic Headlines

India and China IVD Markets Defy Economic Headlines

While in vitro diagnostic testing is not immune to general economic conditions, it is somewhat shielded by its own set of market dynamics not always attached to stock prices and quarterly results. Healthcare spending and hospital construction, underserved populations and increasing urban migration drive tests. Kalorama has just released IVD in India: http://www.kaloramainformation.com/IVD-India-9596771/ Our current study of Indian IVD markets finds growth despite recent concerns about Asian mark...


Take Stock of the LDT Market Landscape with the New Kalorama Information White Paper

Take Stock of the LDT Market Landscape with the New Kalorama Information White Paper

Kalorama Information offers comprehensive analysis of the cancer diagnostics market, including cancer testing services, with The World Market for Cancer Diagnostics, 6 th Edition. The free white paper regarding laboratory-developed oncology tests is available here.

The test service model has become a leading strategy for laboratories and even some IVD companies looking to expand their footprint in the cancer diagnostics market. In the leading U.S. market, company-owned test services have long ...

  • by bcarlson@marketresearch.com
  • January 20 2016


No Concern for Device Industry Seen in J&J Restructuring

No Concern for Device Industry Seen in J&J Restructuring

The recent medical device-related layoffs at Johnson & Johnson is an impactful decision for the company and on its employees. But it does not signal any downturn in the medical device market, as the New Brunswick, N.J. - based device giant has been selling off parts of its devices business in recent years, and J&J’s declines should reflect increases in other companies. The global market for medical devices was $370 billion dollars in 2015, and is expected to grow at 3% average growth per year, a...


Affymetrix Acquisition Deepens and Complements Thermo Fisher’s Existing Product Groups in Clinical Molecular Testing, Translational Research, Flow Cytometry and Applied Testing

Affymetrix Acquisition Deepens and Complements Thermo Fisher’s Existing Product Groups in Clinical Molecular Testing, Translational Research, Flow Cytometry and Applied Testing

Kalorama Information offers additional analysis of the markets discussed below with an upcoming title on clinical and research microarrays as well as published reports including The Market for Prenatal, Newborn and Carrier Genetic Testing , The World Market for Cancer Diagnostics, 6 th Ed. , Proteomics Research Markets , The World Market for Flow Cytometry in IVD Applications , and The World Market for Veterinary Diagnostics.

Thermo Fisher Scientific’s reach in the global life sciences market ...

  • by bcarlson@marketresearch.com
  • January 5 2016


Five IVD Market Trends to Watch for in 2016

Five IVD Market Trends to Watch for in 2016

These developments are important for those watching the IVD market. Lab Developed Tests, China and IVD, Continued Mergers and Acquisitions, and other trends are affecting in vitro diagnostic companies. Kalorama Information publishes The Worldwide Market for In Vitro Diagnostic Tests every two years.